Clinical trial
Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
NCT00305799 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00305799 |
|---|---|
| Title | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors |
| Official title | Auditory and Vestibular Function Evaluation in Patients With Solid Tumors Treated With Oxaliplatin-Containing Chemotherapy |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Procedure |
| Interventions | management of therapy complications |
| Enrollment | 59 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Nov 1, 2014 |
| First posted | Mar 22, 2006 |
| Last update posted | Nov 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: